About RedHill Biopharma
RedHill Biopharma is a company based in Ramat Gan (Israel) founded in 2009.. RedHill Biopharma has raised $13.5 million across 12 funding rounds from investors including Cosmo Pharmaceuticals, Migdal Group and Orbimed. The company has 35 employees as of December 31, 2024. RedHill Biopharma operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others.
- Headquarter Ramat Gan, Israel
- Employees 35 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Redhill Biopharma Ltd. Sponsored Adr
-
Annual Revenue
$8.08 M24.07as on Dec 31, 2024
-
Net Profit
$-8.31 M-134.82as on Dec 31, 2024
-
EBITDA
$-11.69 M60.19as on Dec 31, 2024
-
Total Equity Funding
$13.5 M (USD)
in 12 rounds
-
Latest Funding Round
$10 M (USD), Post-IPO
Jan 25, 2024
-
Investors
Cosmo Pharmaceuticals
& 12 more
-
Employee Count
35
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of RedHill Biopharma
RedHill Biopharma is a publicly listed company on the NASDAQ with ticker symbol RDHL in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Leadership Team
8 people
Sales and Marketing
2 people
Operations Team
2 people
Unlock access to complete
Funding Insights of RedHill Biopharma
RedHill Biopharma has successfully raised a total of $13.5M across 12 strategic funding rounds. The most recent funding activity was a Post-IPO round of $10 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 12
- Last Round Post-IPO — $10.0M
-
First Round
First Round
(12 Sep 2010)
- Investors Count 13
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2024 | Amount | Post-IPO - RedHill Biopharma | Valuation |
investors |
|
| Oct, 2023 | Amount | Post-IPO - RedHill Biopharma | Valuation |
investors |
|
| Aug, 2023 | Amount | Post-IPO - RedHill Biopharma | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in RedHill Biopharma
RedHill Biopharma has secured backing from 13 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Cosmo Pharmaceuticals, Migdal Group and Orbimed. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
Investment opportunities in healthcare are managed by Broadfin Capital.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by RedHill Biopharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - RedHill Biopharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Redhill Biopharma Comparisons
Competitors of RedHill Biopharma
RedHill Biopharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Redhill Biopharma
Frequently Asked Questions about RedHill Biopharma
When was RedHill Biopharma founded?
RedHill Biopharma was founded in 2009 and raised its 1st funding round 1 year after it was founded.
Where is RedHill Biopharma located?
RedHill Biopharma is headquartered in Ramat Gan, Israel. It is registered at Ramat Gan, Tel Aviv District, Israel.
Is RedHill Biopharma a funded company?
RedHill Biopharma is a funded company, having raised a total of $13.5M across 12 funding rounds to date. The company's 1st funding round was a Post-IPO of $2.7M, raised on Sep 12, 2010.
How many employees does RedHill Biopharma have?
As of Dec 31, 2024, the latest employee count at RedHill Biopharma is 35.
What is the annual revenue of RedHill Biopharma?
Annual revenue of RedHill Biopharma is $8.08M as on Dec 31, 2024.
What does RedHill Biopharma do?
Founded in 2009 and headquartered in Ramat Gan, Israel, proprietary orally-administered small molecule drugs are developed by the biopharmaceutical company for gastrointestinal and infectious diseases. The product pipeline encompasses RHB-204 and RHB-104 for H. pylori infections and Crohns disease, RHB-102 for gastroenteritis and gastritis, and RHB-106 for solid tumors, pancreatic cancer, and migraines, among other conditions. Operations center on advancing these therapeutics through clinical stages.
Who are the top competitors of RedHill Biopharma?
RedHill Biopharma's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
Is RedHill Biopharma publicly traded?
Yes, RedHill Biopharma is publicly traded on NASDAQ under the ticker symbol RDHL.
Who are RedHill Biopharma's investors?
RedHill Biopharma has 13 investors. Key investors include Cosmo Pharmaceuticals, Migdal Group, Orbimed, Hebrew University of Jerusalem, and Excellence Investment House.
What is RedHill Biopharma's ticker symbol?
The ticker symbol of RedHill Biopharma is RDHL on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.